242 related articles for article (PubMed ID: 25209105)
21. Choice of Antihypertensive Combination Therapy Based on Daily Salt Intake.
Toyoda S; Inami S; Kato T; Tsukada K; Nakamoto A; Kikegawa Y; Suzuki A; Anraku Y; Node K; Inoue T
Am J Med Sci; 2015 Sep; 350(3):160-6. PubMed ID: 26196407
[TBL] [Abstract][Full Text] [Related]
22. Different effects of L/N-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHR/Izm.
Konda T; Enomoto A; Aritomi S; Niinuma K; Koganei H; Ogawa T; Nitta K
Am J Nephrol; 2009; 30(2):155-61. PubMed ID: 19325231
[TBL] [Abstract][Full Text] [Related]
23. Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin.
Davis BJ; Cao Z; de Gasparo M; Kawachi H; Cooper ME; Allen TJ
J Hypertens; 2003 Jan; 21(1):209-16. PubMed ID: 12544453
[TBL] [Abstract][Full Text] [Related]
24. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
Ferri C; Croce G; Desideri G
Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
[TBL] [Abstract][Full Text] [Related]
25. Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel.
Shimizu H; Nakagami H; Yasumasa N; Mariana OK; Kyutoku M; Koriyama H; Nakagami F; Shimamura M; Rakugi H; Morishita R
Hypertens Res; 2012 Jan; 35(1):77-81. PubMed ID: 21881574
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoids activate cardiac mineralocorticoid receptors in adrenalectomized Dahl salt-sensitive rats.
Ohtake M; Hattori T; Murase T; Takahashi K; Takatsu M; Ohtake M; Miyachi M; Watanabe S; Cheng XW; Murohara T; Nagata K
Nagoya J Med Sci; 2014 Feb; 76(1-2):59-72. PubMed ID: 25129992
[TBL] [Abstract][Full Text] [Related]
27. Long-term administration of amlodipine prevents decompensation to diastolic heart failure in hypertensive rats.
Nishikawa N; Masuyama T; Yamamoto K; Sakata Y; Mano T; Miwa T; Sugawara M; Hori M
J Am Coll Cardiol; 2001 Nov; 38(5):1539-45. PubMed ID: 11691537
[TBL] [Abstract][Full Text] [Related]
28. L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease.
Kanaoka T; Tamura K; Wakui H; Ohsawa M; Azushima K; Uneda K; Kobayashi R; Fujikawa T; Tsurumi-Ikeya Y; Maeda A; Yanagi M; Toya Y; Umemura S
Int J Mol Sci; 2013 Aug; 14(8):16866-81. PubMed ID: 23959116
[TBL] [Abstract][Full Text] [Related]
29. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
Frampton JE; Scott LJ
Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the anti-hypertensive effects of the L/N-type calcium channel antagonist cilnidipine, and the L-type calcium channel antagonist amlodipine in hypertensive patients with cerebrovascular disease.
Takei K; Araki N; Ohkubo T; Tamura N; Yamamoto T; Furuya D; Yanagisawa CT; Shimazu K
Intern Med; 2009; 48(16):1357-61. PubMed ID: 19687579
[TBL] [Abstract][Full Text] [Related]
31. Combination therapy with irbesartan and efonidipine for attenuation of proteinuria in Dahl salt-sensitive rats.
Takai S; Jin D; Sakonjo H; Miyazaki M
Hypertens Res; 2010 Sep; 33(9):953-9. PubMed ID: 20520612
[TBL] [Abstract][Full Text] [Related]
32. Antihypertensive efficacy of olmesartan medoxomil or valsartan in combination with amlodipine: a review of factorial-design studies.
Ram CV
Curr Med Res Opin; 2009 Jan; 25(1):177-85. PubMed ID: 19210150
[TBL] [Abstract][Full Text] [Related]
33. Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.
Duprez D; Ferdinand K; Purkayastha D; Samuel R; Wright R
Vasc Health Risk Manag; 2011; 7():701-8. PubMed ID: 22174580
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan.
da Silva PM
Clin Drug Investig; 2010; 30(9):625-41. PubMed ID: 20626210
[TBL] [Abstract][Full Text] [Related]
35. Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats.
Yamada T; Nagata K; Cheng XW; Obata K; Saka M; Miyachi M; Naruse K; Nishizawa T; Noda A; Izawa H; Kuzuya M; Okumura K; Murohara T; Yokota M
Eur J Pharmacol; 2009 Aug; 615(1-3):163-70. PubMed ID: 19501083
[TBL] [Abstract][Full Text] [Related]
36. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats.
Nakamura T; Fukuda M; Kataoka K; Nako H; Tokutomi Y; Dong YF; Yamamoto E; Yasuda O; Ogawa H; Kim-Mitsuyama S
Hypertens Res; 2011 Jul; 34(7):817-24. PubMed ID: 21471977
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
[TBL] [Abstract][Full Text] [Related]
38. Effects of L/N-type calcium channel antagonist, cilnidipine on progressive renal injuries in Dahl salt-sensitive rats.
Konda T; Enomoto A; Takahara A; Yamamoto H
Biol Pharm Bull; 2006 May; 29(5):933-7. PubMed ID: 16651722
[TBL] [Abstract][Full Text] [Related]
39. Antihypertensive therapy with CCB/ARB combination in older individuals: focus on amlodipine/valsartan combination.
Kostis JB
Am J Ther; 2010; 17(2):188-96. PubMed ID: 19433970
[TBL] [Abstract][Full Text] [Related]
40. A comparison of the effects of fixed dose vs. single-agent combinations on 24-h blood pressure variability.
Ulusoy S; Ozkan G; Konca C; Kaynar K
Hypertens Res; 2012 Nov; 35(11):1111-7. PubMed ID: 22786565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
